Literature DB >> 12027834

Myelopathy in primary Sjögren's syndrome: diagnostic and therapeutic aspects.

M Hermisson1, R Klein, F Schmidt, M Weller, W Küker.   

Abstract

We report a patient with a myelopathy in primary Sjögren's syndrome, proven by salivary gland biopsy and specific antibodies. Under steroid medication, the patient had a remitting and relapsing clinical course. The severity of clinical symptoms correlated with a transient contrast uptake in spinal magnetic resonance imaging. Under a treatment with azathioprine and prednisone the patient has suffered no relapse within the last 20 months. Although this is only a case report, the combination of azathioprine and prednisone may be a valuable medication in chronic cases of Sjögren's syndrome with neurologic symptoms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027834     DOI: 10.1034/j.1600-0404.2002.01167.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  5 in total

Review 1.  Myelopathy in Sjögren's syndrome: role of nonsteroidal immunosuppressants.

Authors:  Susan J Rogers; Christopher S Williams; Gustavo C Román
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Refractory Sjögren's syndrome myelopathy successfully treated with subcutaneous tocilizumab: A case report.

Authors:  Yuichi Ishikawa; Koto Hattori; Junichi Ishikawa; Michio Fujiwara; Yasuhiko Kita
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 3.  Cerebral vasculitis: imaging signs revisited.

Authors:  Wilhelm Küker
Journal:  Neuroradiology       Date:  2007-03-08       Impact factor: 2.995

4.  Human T-Lymphotrophic Virus Type-I: A Unique Association with Myelopathy in Sjögren's Syndrome.

Authors:  Alexandria Voigt; Cuong Q Nguyen
Journal:  Clin Microbiol       Date:  2015

5.  Beyond the Glands: An in-Depth Perspective of Neurological Manifestations in Sjögren's Syndrome.

Authors:  Alexandria Voigt; Sukesh Sukumaran; Cuong Q Nguyen
Journal:  Rheumatology (Sunnyvale)       Date:  2014
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.